Publications by authors named "Nicholas Cammack"

Claim this Profile
G
GSK2556286 Is a Novel Antitubercular Drug Candidate Effective with the Potential To Shorten Tuberculosis Treatment.
Eric L Nuermberger, Maria Santos Martínez-Martínez, Olalla Sanz, Beatriz Urones, Jorge Esquivias, Nicholas C Cammack

Antimicrob Agents Chemother· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tres Cantos Open Lab: celebrating a decade of innovation in collaboration to combat endemic infectious diseases.
Felix Calderón, Lluis Ballell, David Barros, Graeme Bilbe, Nicholas Cammack

Nat Rev Drug Discov· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to The Discovery of Novel Antimalarial Aminoxadiazoles as a Promising Nonendoperoxide Scaffold.
Elena Sandoval, María José Lafuente-Monasterio, María J Almela, Pablo Castañeda, María Belén Jiménez Díaz, Nicholas Cammack

J Med Chem· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Discovery of Novel Antimalarial Aminoxadiazoles as a Promising Nonendoperoxide Scaffold.
Elena Sandoval, María José Lafuente-Monasterio, María J Almela, Pablo Castañeda, María Belén Jiménez Díaz, Nicholas Cammack

J Med Chem· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of KasA as the cellular target of an anti-tubercular scaffold.
Katherine A Abrahams, Chun-Wa Chung, Sonja Ghidelli-Disse, Joaquín Rullas, María José Rebollo-López, Nicholas C Cammack

Nat Commun· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Release of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discovery.
María Jose Rebollo-Lopez, Joël Lelièvre, Daniel Alvarez-Gomez, Julia Castro-Pichel, Francisco Martínez-Jiménez, Nicholas Cammack

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open Lab as a source of hits and leads against tuberculosis, malaria and kinetoplastid diseases.
Lluís Ballell, Mike Strange, Nicholas Cammack, Alan H Fairlamb, Leszek Borysiewicz

Nat Rev Drug Discov· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
THPP target assignment reveals EchA6 as an essential fatty acid shuttle in mycobacteria.
Jonathan A G Cox, Katherine A Abrahams, Carlos Alemparte, Sonja Ghidelli-Disse, Joaquín Rullas, Nicholas C Cammack

Nat Microbiol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Novel Anti-mycobacterial Compounds by Screening a Pharmaceutical Small-Molecule Library against Nonreplicating Mycobacterium tuberculosis.
Thulasi Warrier, Maria Martinez-Hoyos, Manuel Marin-Amieva, Gonzalo Colmenarejo, Esther Porras-De Francisco, Nicholas Cammack

ACS Infect Dis· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Study of Small Molecules As Antimalarials: 2-Amino-1-phenylethanol (APE) Derivatives.
María J Chaparro, Jaume Vidal, Iñigo Angulo-Barturen, José M Bueno, Jeremy Burrows, Nicholas Cammack

ACS Med Chem Lett· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide and N-benzyl-6',7'-dihydrospiro[piperidine-4,4'-thieno[3,2-c]pyran] analogues with bactericidal efficacy against Mycobacterium tuberculosis targeting MmpL3.
Modesto J Remuiñán, Esther Pérez-Herrán, Joaquín Rullás, Carlos Alemparte, María Martínez-Hoyos, Nicholas Cammack

PLoS One· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fueling open-source drug discovery: 177 small-molecule leads against tuberculosis.
Lluís Ballell, Robert H Bates, Rob J Young, Daniel Alvarez-Gomez, Emilio Alvarez-Ruiz, Nicholas Cammack

ChemMedChem· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis